Furthermore, as the study is a re-analysis of blood samples from a placebo-controlled interventional trial on pharmacologic p38 MAP kinase inhibition in endotoxemia [4,5], the intake of tryptophan was not standardized. This evidence concerns the gene MAPK14 and serum lipopolysaccharide activity.